Abiopharma

🔍 Chersi Robert J (Director)

Company: Bausch & Lomb Corp (BLCO)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Acquired 11,776 shares of Common Shares, No Par Value (Direct)
  Date: 2026-08-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,776.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.